InvestorsHub Logo
Followers 58
Posts 10155
Boards Moderated 1
Alias Born 09/21/2016

Re: TC65 post# 151600

Monday, 06/04/2018 3:00:04 PM

Monday, June 04, 2018 3:00:04 PM

Post# of 462581
Looking..Great catch here:

So do the introduction of new scientific domains into the development and review process. This includes the more widespread use of modeling and simulation, the greater use of real-world evidence in the pre- and post-market setting, and the adoption of better tools for collecting and evaluating more real-time safety information after products are approved.



Exactly right ref greater use of RWE...

even after products are approved

. That is just being smart and possibly a reaction to both the AD Amyloid screw ups and the recent Breast cancer-Chemo disclosures. The FDA has been acting as a gate keeper for regulatory script w/o being on the team.

IMO, the got the memo and will be closely working w/sponsors such as AVXL.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News